Staging lymph node metastases from lung cancer in the mediastinum

Mario D. Terán, Malcolm V Brock

Research output: Contribution to journalArticle

Abstract

Background: The presence of tumor metastases in the mediastinum is one of the most important elements in determining the optimal treatment strategy in patients with non-small cell lung cancer. This review is aimed at examining the current strategies for investigating lymph node metastases corresponding to an "N2" classification delineated by The International Staging Committee of the International Association for the Study of Lung Cancer (IASLC). Methods: Extensive review of the existing scientific literature related to the investigation of mediastinal lymph node metastases was undertaken in order to summarize and report current best practices. Conclusions: N2 disease is very heterogeneous requiring multiple modalities for thorough investigation. New research is now focusing on better identifying, defining, and classifying lymph node metastases in the mediastinum. Molecular staging and sub-classifying mediastinal lymph node metastases are being actively researched in order to provide better prognostic value and to optimize treatment strategies. Non-invasive imaging, such as PET/CT and minimally invasive techniques such as endobronchial and endoscopic ultrasound guided biopsy, are now the lead investigative methods in evaluating the mediastinum for metastatic presence.

Original languageEnglish (US)
Pages (from-to)230-236
Number of pages7
JournalJournal of Thoracic Disease
Volume6
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Mediastinal Neoplasms
Lung Neoplasms
Lymph Nodes
Neoplasm Metastasis
Mediastinum
Literature
Practice Guidelines
Non-Small Cell Lung Carcinoma
Biopsy
Therapeutics
Research
Neoplasms

Keywords

  • Lung cancer
  • lymph node staging
  • mediastinal metastasis
  • N2 disease

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Staging lymph node metastases from lung cancer in the mediastinum. / Terán, Mario D.; Brock, Malcolm V.

In: Journal of Thoracic Disease, Vol. 6, No. 3, 2014, p. 230-236.

Research output: Contribution to journalArticle

@article{972e009c19df424c83e6a9796456094a,
title = "Staging lymph node metastases from lung cancer in the mediastinum",
abstract = "Background: The presence of tumor metastases in the mediastinum is one of the most important elements in determining the optimal treatment strategy in patients with non-small cell lung cancer. This review is aimed at examining the current strategies for investigating lymph node metastases corresponding to an {"}N2{"} classification delineated by The International Staging Committee of the International Association for the Study of Lung Cancer (IASLC). Methods: Extensive review of the existing scientific literature related to the investigation of mediastinal lymph node metastases was undertaken in order to summarize and report current best practices. Conclusions: N2 disease is very heterogeneous requiring multiple modalities for thorough investigation. New research is now focusing on better identifying, defining, and classifying lymph node metastases in the mediastinum. Molecular staging and sub-classifying mediastinal lymph node metastases are being actively researched in order to provide better prognostic value and to optimize treatment strategies. Non-invasive imaging, such as PET/CT and minimally invasive techniques such as endobronchial and endoscopic ultrasound guided biopsy, are now the lead investigative methods in evaluating the mediastinum for metastatic presence.",
keywords = "Lung cancer, lymph node staging, mediastinal metastasis, N2 disease",
author = "Ter{\'a}n, {Mario D.} and Brock, {Malcolm V}",
year = "2014",
doi = "10.3978/j.issn.2072-1439.2013.12.18",
language = "English (US)",
volume = "6",
pages = "230--236",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "3",

}

TY - JOUR

T1 - Staging lymph node metastases from lung cancer in the mediastinum

AU - Terán, Mario D.

AU - Brock, Malcolm V

PY - 2014

Y1 - 2014

N2 - Background: The presence of tumor metastases in the mediastinum is one of the most important elements in determining the optimal treatment strategy in patients with non-small cell lung cancer. This review is aimed at examining the current strategies for investigating lymph node metastases corresponding to an "N2" classification delineated by The International Staging Committee of the International Association for the Study of Lung Cancer (IASLC). Methods: Extensive review of the existing scientific literature related to the investigation of mediastinal lymph node metastases was undertaken in order to summarize and report current best practices. Conclusions: N2 disease is very heterogeneous requiring multiple modalities for thorough investigation. New research is now focusing on better identifying, defining, and classifying lymph node metastases in the mediastinum. Molecular staging and sub-classifying mediastinal lymph node metastases are being actively researched in order to provide better prognostic value and to optimize treatment strategies. Non-invasive imaging, such as PET/CT and minimally invasive techniques such as endobronchial and endoscopic ultrasound guided biopsy, are now the lead investigative methods in evaluating the mediastinum for metastatic presence.

AB - Background: The presence of tumor metastases in the mediastinum is one of the most important elements in determining the optimal treatment strategy in patients with non-small cell lung cancer. This review is aimed at examining the current strategies for investigating lymph node metastases corresponding to an "N2" classification delineated by The International Staging Committee of the International Association for the Study of Lung Cancer (IASLC). Methods: Extensive review of the existing scientific literature related to the investigation of mediastinal lymph node metastases was undertaken in order to summarize and report current best practices. Conclusions: N2 disease is very heterogeneous requiring multiple modalities for thorough investigation. New research is now focusing on better identifying, defining, and classifying lymph node metastases in the mediastinum. Molecular staging and sub-classifying mediastinal lymph node metastases are being actively researched in order to provide better prognostic value and to optimize treatment strategies. Non-invasive imaging, such as PET/CT and minimally invasive techniques such as endobronchial and endoscopic ultrasound guided biopsy, are now the lead investigative methods in evaluating the mediastinum for metastatic presence.

KW - Lung cancer

KW - lymph node staging

KW - mediastinal metastasis

KW - N2 disease

UR - http://www.scopus.com/inward/record.url?scp=84896056801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896056801&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2072-1439.2013.12.18

DO - 10.3978/j.issn.2072-1439.2013.12.18

M3 - Article

C2 - 24624287

AN - SCOPUS:84896056801

VL - 6

SP - 230

EP - 236

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 3

ER -